@_OpenPharma profile picture
Open Pharma @_OpenPharma
Joined April 2017
  • Tweets 7,841
  • Following 393
  • Followers 1,001
171 Photos and videos
Pinned Tweet
Open Pharma@_OpenPharma
12 Feb 2025
We’re no longer posting on this account. Want to stay up to date with all things Open Pharma? Be sure to follow us on Bluesky (openpharma.bsky.social) and LinkedIn (linkedin.com/showcase/open-p…). #OpenPharma #Bluesky #NewBeginnings
47
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess #MedicalPublishing #GenAI #AI #REF2029 #OpenResearch #ScholarlyPublishing openpharma.blog/blog/news/we…

Weekly digest: AI for research assessment processes, open access and the FAIR principles

This week, we read about how GenAI can support Research Excellence Framework assessments, and we take a deep dive into the broad benefits of OA publishing. We also read reflections on open science...

openpharma.blog
73
📖 Discover how #OpenPharma is contributing to the global commitment of universal access to healthcare information in our latest blog post. #OpenScience #Healthcare #PLS #OpenAccess #MedicalResearch #MedicalPublishing openpharma.blog/blog/opinion…

Global context and commitments at the start of a new year

The individual projects that Open Pharma champions contribute to a wider paradigm shift in the way healthcare information is produced, published and accessed. During this time for reflection at the...

openpharma.blog
2
64
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess #ImpactMetrics #MedicalPublishing #AI #DiamondOA #Copyright #OpenData openpharma.blog/blog/news/we…

Weekly digest: impact metrics, AI articles and EDCH launch

This week, we watch an interview with Laura Dormer about the future of research impact metrics. We read about a hackathon that demonstrated the strengths and limitations of using AI to support...

openpharma.blog
32
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess #SDGs #SustainablePublishing #MedicalPublishing #ResearchMisconduct openpharma.blog/blog/news/we…

Weekly digest: sustainable publishing, funding OA research and ICMJE updates

This week, we share a call for feedback on the STM SDG Classifier Demonstrator and remind readers to register for an upcoming OASPA webinar. We read about recent updates to the ICMJE recommendations...

openpharma.blog
29
Find out what Open Pharma has been up to recently in our quarterly update! 👇 #OpenScience #OpenAccess #InternationalOpenAccessWeek #PlainLanguageSummaries #MedicalAffairs #PatientCentricity #RegisteredReports openpharma.blog/blog/news/op…

Open Pharma quarterly update: October–December 2024

Read about what we've been up to this quarter!

openpharma.blog
19
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess #AcademicPublishing #AI #Copyright #Metascience #StateOfOpenData #PeerReview #OpenResearch openpharma.blog/blog/news/we…

Weekly digest: AI for academic publishing, publishing agreements and WithdrarXiv

This week, we listen to the latest AI for Pharma Growth podcast about the opportunities AI offers to academic publishing. We signpost two upcoming webinars, one about publisher copyright agreements...

openpharma.blog
40
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess @OASPA #ISMPPEurope2025 #OpenScienceMonitoring #AI #ArtificialIntelligence @UNL_Lib @RoySocChem openpharma.blog/blog/news/we…

Weekly digest: OA funder perspectives, ISMPP Europe 2025 and OSMI working groups

Happy New Year! In this first digest of 2025, we highlight an upcoming webinar from OASPA about the role of public and private research funders in OA publishing. We remind readers to register for the...

openpharma.blog
39
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess @NIH #PublicAccess #OA #ResponsibleAI #ArtificialIntelligence @PLOS @gatesfoundation #ResearchManagement openpharma.blog/blog/news/we…

Weekly digest: NIH Public Access Policy, responsible AI and APC-free publishing

This week, we learn about the NIH’s new Public Access Policy, which aims to make NIH-funded research outputs available as quickly as possible. We explore Elsevier’s collaborative approach to building...

openpharma.blog
2
1
41
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess #RegisteredReports #FAIRData #DataSharing #PredatoryPublishing #OneNationOneSubscription #AI openpharma.blog/blog/news/we…

Weekly digest: Lilly joins Open Pharma, Registered Reports and WorldFAIR

This week, we’re delighted to announce that Lilly has become Open Pharma’s latest Member! We read our latest guest post from Erick Turner and Chris Chambers, who propose a way to harmonize the...

openpharma.blog
1
40
🎉 Lilly joins Open Pharma! Read the full press release on our blog. #OpenPharma #OpenScience #Welcome #Pharma openpharma.blog/blog/news/li…

Lilly becomes a Member of Open Pharma

Open Pharma is proud to announce that Eli Lilly and Company has joined Open Pharma as a Member.

openpharma.blog
2
61
The #RegisteredReports (RR) peer review process avoids publication bias, helping clinicians to judge drug efficacy and safety accurately. In this post, @eturnermd1 and @chrisdc77 propose a way to harmonize RR with the FDA drug approval process. Read at: shorturl.at/ZlA7k

Leveraging Registered Reports to increase transparency in trial publication – Open Pharma -...

Publication bias undermines the credibility of clinical trial reporting and negatively affects the reputation of pharma sponsors. Registered Reports (RR) is a peer review process designed to eradic...

openpharma.blog
4
4
1,187
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess @digitalsci @SpringerNature @figshare #StateOfOpenData @OASPA @bmj_latest #Metadata @Official_EMWA #EMWA58 openpharma.blog/blog/news/we…

Weekly digest: State of Open Data 2024, OASPA equity recommendations and patient reviewer remuner...

This week, we explore the 2024 State of Open Data Special Report and the new OASPA recommendations for increasing equity in OA publishing. We also learn about The BMJ’s new patient and public...

openpharma.blog
1
3
334
📢Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess @WeAreTandF #PlainLanguageSummary @ScholarlyPub #UniversityPress @altmetric #ClinicalGuidelines #OpenResearch openpharma.blog/blog/news/we…

Weekly digest: PLS innovations, university press insights, and Altmetric updates

This week, we signpost an upcoming webinar from Taylor & Francis that will explore innovations in PLS, and we listen to the latest SSP Early Career Development Podcast about the role of university...

openpharma.blog
1
1
81
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess #MedComms #Preprints @WeAreTandF #AcademicEditing #AI #ArtificialIntelligence @STM_Publishing openpharma.blog/blog/news/we…

Weekly digest: AI in medical storytelling, preprints and collective OA funding

This week, we listen to a podcast exploring the role of AI in medical storytelling. We delve into the role of preprints in academic publishing and read about the influence of academic editing on the...

openpharma.blog
3
1
3
88
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess @PKP @BarcelonaDORI #Accessibility #NelsonMemo #GreenOpenAccess #GenAI #AI @OASPA #MedComms openpharma.blog/blog/news/we…

Weekly digest: transparency and integrity in open access, compliance, and the OASPA Conference

This week, we highlight an innovative tool to drive transparency and integrity in publishing, signpost the conference proceedings from the 2024 OASPA Conference and dissect the impact of AI on...

openpharma.blog
35
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess @ISMPP #ISMPPAcademy @WileyGlobal #AI #MedPubs #PeerReview @copyrightclear #Copyright #MedComms openpharma.blog/blog/news/we…

Weekly digest: ISMPP Academy, Wiley’s AI commitment, and copyright protection

This week, we signpost the upcoming ISMPP Academy meeting in Philadelphia, USA, which will feature a presentation by Oxford PharmaGenesis’ own Richard White. We read about Wiley’s approach to...

openpharma.blog
40
📢 Read this week’s #OpenPharma digest here! Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess @ISMPP #ISMPPEurope2025 @R2RConf @UNESCO #DiamondOA @medwma #DeclarationOfHelsinki2024 openpharma.blog/blog/news/we…

Weekly digest: ISMPP, Researcher to Reader Conference and UNESCO diamond OA

This week, we encourage you to register for the 2025 European Meeting of ISMPP and the 10th annual Researcher to Reader Conference. We share the latest consultation from the UNESCO Global Diamond OA...

openpharma.blog
1
42
Sign up to our blog to receive weekly #OpenScience news and more straight to your inbox! #OpenAccess #OA #OAWeek #Copyright #CCLicences #CreativeCommons @biorxivpreprint @ISMPP @SPARC_NA openpharma.blog/blog/news/we…

Weekly digest: reflecting on Open Access Week 2024

This week, we reflect on International Open Access Week 2024 and feature resources to help you understand and adopt OA. We share our analysis of medical research OA publication trends and highlight...

openpharma.blog
43
👂Have you heard …? We’re delighted to announce the publication of our preprint titled ‘Benchmarking open access publication rates for the pharmaceutical industry and research-intensive academic institutions’: biorxiv.org/content/10.1101/….

Benchmarking open access publication rates for the pharmaceutical industry and research-intensive...

Objective In biomedical and health sciences, many articles are published open access (OA). Rates of OA publications continue to grow, including for research carried out by pharmaceutical companies....

biorxiv.org
1
2
1
88
Don’t have time to read the preprint? To celebrate International #OAWeek, we’ve used #AI to transform it into a song! 🎵 Listen to the ‘plain language song’ here 👇 youtu.be/N3EdwoqKudU #OpenScience #OpenAccess #OpenPharma #KnowledgeIsPower #SciComms #SciPubs #Preprints

Open access roundup | An AI sing-along summary

To celebrate International Open Access Week 2024, we've used artifi...

youtube.com
2
1
72
Load more